Latest Tysabri news
Enhanced Atypical Lymphocytes in Natalizumab-Treated MS
posted May 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
For patients with relapsing-remitting multiple sclerosis, natalizumab treatment is associated with enhancement of atypical lymphocytes, especially binucleated and plasmacytoid lymphocytes, according to a study published online May 8 in the International Journal of Laboratory Hematology.
Tysabri Impacts Seroconversion in John Cunningham Virus
posted January 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
For patients with John Cunningham virus (JCV), natalizumab (Tysabri) treatment affects seroconversion and JCV index values, according to a study published online Jan. 27 in Neurology: Neuroimmunology & Neuroinflammation.
Frequent TV Watching Linked to Smaller Brain Volume 
ADHD Poses Additional Concussion Challenges for Athletes 
High Levels of Light Exposure Linked to Lower Dementia Risk .jpeg)
Neurodegenerative Mortality Elevated for NFL Athletes 
Study IDs Dementia Risk Factors in Those Older Than 90 Years 
Vascular Burden in Midlife Linked to Increased Risk for Dementia, Death .jpg)
Hispanic Patients Face Delays in Frontotemporal Dementia Diagnosis 
Productivity Loss Precedes Diagnosis of Early-Onset Dementia Monthly Specialist Briefings
Stay Connected
